This is an online activity in hematopathology that offers 2.0 continuing education (CME/CMLE) credit that can be used to fulfill CC Part II and CMP requirements.
Authors
Nagehan Pakasticali, MD
Department of Pathology and Cell Biology
University of South Florida Morsani College of Medicine
Authors
Nagehan Pakasticali, MD
Department of Pathology and Cell Biology
University of South Florida Morsani College of Medicine
Julie Y. Li, MD
Department of Pathology
Moffitt Cancer Center
Tampa, Florida
Primary Audience: Pathologists and Clinical Scientists
Secondary Audience: Residents, Laboratory Technologist/Scientist (Includes all sub-specialty areas), Students, Pathologist Assistants, Laboratory Directors and Educators
Upon completion of this activity, you will be able to:
- recognize the clinicopathologic characteristics of chronic neutrophilic leukemia (CNL);
- discuss the underlying pathogenesis, particularly activating mutations in CSF3R;
- summarize the updated diagnostic criteria for CNL as outlined in both the 2022 International Consensus Classification and the fifth edition of the World Health Organization classification; and
- differentiate CNL from reactive neutrophilia, chronic myeloid leukemia, and atypical chronic myeloid leukemia.